AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $841,000 | -44.5% | 117,227 | +9.7% | 0.00% | -50.0% |
Q1 2019 | $1,514,000 | +8.0% | 106,827 | +3.1% | 0.00% | 0.0% |
Q4 2018 | $1,402,000 | +15.0% | 103,615 | +88.6% | 0.00% | +33.3% |
Q3 2018 | $1,219,000 | +33.5% | 54,953 | -1.2% | 0.00% | +50.0% |
Q2 2018 | $913,000 | – | 55,633 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |